Assessing the efficacy of changing to Travoprost/Timolol fixed combination, as replacement therapy in patients on prostaglandin monotherapy

Trial Profile

Assessing the efficacy of changing to Travoprost/Timolol fixed combination, as replacement therapy in patients on prostaglandin monotherapy

Completed
Phase of Trial: Phase II/III

Latest Information Update: 17 May 2016

At a glance

  • Drugs Travoprost/timolol (Primary)
  • Indications Glaucoma; Ocular hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Oct 2015 New trial record
    • 30 Sep 2015 Results published in the Advances in Therapy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top